| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc. (KYMR) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. KYMR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.96M | $719.45M | - | |
| Dir | 2.22M | $200.74M | - | |
| Dir | 685.4K | $61.98M | - | |
| CEO | 666.2K | $60.24M | - | |
| CFO | 306.6K | $27.73M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2021 | Mainolfi Nello70 | Chief Executive Officer | Sale+OE | 48,000 | $33.62 | $1,613,562.90 | -2.1% | +58.3% | +16.1% | |
| Mar 15, 2021 | Gollob Jared70 | Chief Medical Officer | Sale+OE | 15,000 | $60.13 | $901,990.83 | -14.6% | -15.7% | -40.6% | |
| Mar 15, 2021 | Jacobs Bruce N.74 | Chief Financial Officer | Sale+OE | 10,000 | $60.15 | $601,527.55 | -100% | -15.7% | -40.6% | |
| Mar 12, 2021 | Atlas Venture Associates X, L.P.88 | 10% Owner | Sell | 229,350 | $56.50 | $12,958,275.00 | -100% | -13.5% | -36.0% | |
| Mar 12, 2021 | Booth Bruce70 | Director | Sell | 229,350 | $56.50 | $12,958,275.00 | -100% | -13.5% | -36.0% | |
| Mar 8, 2021 | Jacobs Bruce N.74 | Chief Financial Officer | Sale+OE | 10,000 | $50.65 | $506,470.09 | -81.3% | - | - | |
| Mar 3, 2021 | Jacobs Bruce N.74 | Chief Financial Officer | Sale+OE | 20,000 | $44.78 | $895,633.79 | -58.4% | - | - | |
| Feb 24, 2021 | Gollob Jared70 | Chief Medical Officer | Sell | 37,064 | $50.68 | $1,878,355.25 | -17.1% | - | - | |
| Feb 19, 2021 | Gollob Jared70 | Chief Medical Officer | Sell | 22,936 | $56.42 | $1,293,935.66 | -7.6% | - | - |